Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome.
Palazzuoli A, Mancone M, De Ferrari GM, Forleo G, Secco GG, Ruocco GM, D'Ascenzo F, Monticone S, Paggi A, Vicenzi M, Palazzo AG, Landolina M, Taravelli E, Tavazzi G, Blasi F, Infusino F, Fedele F, De Rosa FG, Emmett M, Schussler JM, Tecson KM, McCullough PA.
Palazzuoli A, et al. Among authors: ruocco gm.
J Am Heart Assoc. 2020 Nov 17;9(22):e017364. doi: 10.1161/JAHA.120.017364. Epub 2020 Oct 7.
J Am Heart Assoc. 2020.
PMID: 33023356
Free PMC article.